CIK 0001572616
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
FRACTYL HEALTH, INC.
Sign in to watch- Ticker
- GUTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273553477
- Phone
- +1 781-902-8800
- Business address
- 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
- Former names
- Fractyl Laboratories Inc.
- Open-market buys, last 90 days
- $39,903
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$39,903. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Caplan Jay David President, Chief Product Off. | Grant or award · Stock Option (right to buy) | +845,226 | 845,226 | ||
| 2025-02-27 | Caplan Jay David President, Chief Product Off. | Grant or award · Stock Option (right to buy) | +179,700 | 179,700 | ||
| 2025-02-27 | Caplan Jay David President, Chief Product Off. | Grant or award · Stock Option (right to buy) | +104,400 | 104,400 | ||
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Exercise or conversion 10b5-1 | +22,346 | $1.70 | $38K | 175,890 |
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Sale 10b5-1 | −22,346 | $1.81 | $40K | 153,544 |
| 2025-01-31 | Caplan Jay David President, Chief Product Off. | Exercise or conversion · Stock Option 10b5-1 | −22,346 | 17,924 | ||
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Exercise or conversion 10b5-1 | +21,472 | $1.70 | $37K | 175,016 |
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Sale 10b5-1 | −21,472 | $1.95 | $42K | 153,544 |
| 2025-01-30 | Caplan Jay David President, Chief Product Off. | Exercise or conversion · Stock Option 10b5-1 | −21,472 | 40,270 | ||
| 2024-11-11 | Caplan Jay David President, Chief Product Off. | Sale | −64,197 | $2.47 | $159K | 153,544 |
| 2024-11-10 | Caplan Jay David President, Chief Product Off. | Exercise or conversion | +187,257 | 217,741 | ||
| 2024-11-10 | Caplan Jay David President, Chief Product Off. | Exercise or conversion · Restricted Stock Unit | −187,257 | 0 | ||
| 2024-09-12 | Caplan Jay David President, Chief Product Off. | Exercise or conversion | +95,484 | $1.70 | $162K | 95,484 |
| 2024-09-12 | Caplan Jay David President, Chief Product Off. | Sale | −65,000 | $2.90 | $188K | 30,484 |
| 2024-09-12 | Caplan Jay David President, Chief Product Off. | Exercise or conversion · Stock Option | −95,484 | 0 | ||
| 2024-02-06 | Caplan Jay David President, Chief Product Off. | Conversion | +23,299 | 358,806 | ||
| 2024-02-06 | Caplan Jay David President, Chief Product Off. | Conversion | +118,810 | 118,810 | ||
| 2024-02-06 | Caplan Jay David President, Chief Product Off. | Conversion · Series A Preferred Stock | −50,000 | 0 | ||
| 2024-02-06 | Caplan Jay David President, Chief Product Off. | Conversion · Series B Preferred Stock | −177,726 | 0 | ||
| 2024-02-06 | Caplan Jay David President, Chief Product Off. | Conversion · Series C-1 Preferred Stock | −44,730 | 0 |
Page 1 of 2 · 21 trades